These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 647691)
1. Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen. Levin W; Wood AW; Chang RL; Yagi H; Mah HD; Jerina DM; Conney AH Cancer Res; 1978 Jun; 38(6):1831-4. PubMed ID: 647691 [TBL] [Abstract][Full Text] [Related]
2. High tumorigenicity of the 3,4-dihydrodiol of 7-methylbenz[c]acridine on mouse skin and in newborn mice. Chang RL; Levin W; Wood AW; Shirai N; Ryan AJ; Duke CC; Jerina DM; Holder GM; Conney AH Cancer Res; 1986 Sep; 46(9):4552-5. PubMed ID: 3731110 [TBL] [Abstract][Full Text] [Related]
3. Tumor-initiating activity of benz[c]acridine and twelve of its derivatives on mouse skin. Levin W; Wood AW; Chang RL; Kumar S; Yagi H; Jerina DM; Lehr RE; Conney AH Cancer Res; 1983 Oct; 43(10):4625-8. PubMed ID: 6883319 [TBL] [Abstract][Full Text] [Related]
4. Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene. Hecht SS; Rivenson A; Hoffmann D Cancer Res; 1980 May; 40(5):1396-9. PubMed ID: 7370979 [TBL] [Abstract][Full Text] [Related]
5. Tumorigenicity of dihydrodiols and diol-epoxides of benz[c]acridine in newborn mice. Chang RL; Levin W; Wood AW; Kumar S; Yagi H; Jerina DM; Lehr RE; Conney AH Cancer Res; 1984 Nov; 44(11):5161-4. PubMed ID: 6488176 [TBL] [Abstract][Full Text] [Related]
6. Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin. Hecht SS; Radok L; Amin S; Huie K; Melikian AA; Hoffmann D; Pataki J; Harvey RG Cancer Res; 1985 Apr; 45(4):1449-52. PubMed ID: 3838497 [TBL] [Abstract][Full Text] [Related]
7. Tumorigenicity of enantiomers of chrysene 1,2-dihydrodiol and of the diastereomeric bay-region chrysene 1,2-diol-3,4-epoxides on mouse skin and in newborn mice. Chang RL; Levin W; Wood AW; Yagi H; Tada M; Vyas KP; Jerina DM; Conney AH Cancer Res; 1983 Jan; 43(1):192-6. PubMed ID: 6847768 [No Abstract] [Full Text] [Related]
8. High stereoselectivity among the optical isomers of the diastereomeric bay-region diol-epoxides of benz(a)anthracene in the expression of tumorigenic activity in murine tumor models. Levin W; Chang RL; Wood AW; Yagi H; Thakker DR; Jerina DM; Conney AH Cancer Res; 1984 Mar; 44(3):929-33. PubMed ID: 6692415 [TBL] [Abstract][Full Text] [Related]
9. Tumor-initiating activity and metabolism of polymethylated phenanthrenes. LaVoie EJ; Bedenko V; Tulley-Freiler L; Hoffmann D Cancer Res; 1982 Oct; 42(10):4045-9. PubMed ID: 7105001 [TBL] [Abstract][Full Text] [Related]
10. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin. Slaga TJ; Gleason GL; DiGiovanni J; Sukumaran KB; Harvey RG Cancer Res; 1979 Jun; 39(6 Pt 1):1934-6. PubMed ID: 109189 [TBL] [Abstract][Full Text] [Related]
11. Tumorigenicity of optical isomers of the diastereomeric bay-region 3,4-diol-1,2-epoxides of benzo(c)phenanthrene in murine tumor models. Levin W; Chang RL; Wood AW; Thakker DR; Yagi H; Jerina DM; Conney AH Cancer Res; 1986 May; 46(5):2257-61. PubMed ID: 3697970 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of benzo[c]chrysene and comparative mammary gland tumorigenesis of benzo[c]chrysene bay and fjord region diol epoxides in female CD rats. Amin S; Lin JM; Krzeminski J; Boyiri T; Desai D; El-Bayoumy K Chem Res Toxicol; 2003 Feb; 16(2):227-31. PubMed ID: 12588194 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and tumorigenicity of 7-, 8-, 9-, and 10-fluorobenzo(a)pyrenes. Buhler DR; Unlu F; Thakker DR; Slaga TJ; Newman MS; Levin W; Conney AH; Jerina DM Cancer Res; 1982 Nov; 42(11):4779-83. PubMed ID: 6290047 [TBL] [Abstract][Full Text] [Related]
14. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene. Amin S; Huie K; Melikian AA; Leszczynska JM; Hecht SS Cancer Res; 1985 Dec; 45(12 Pt 1):6406-42. PubMed ID: 4063989 [TBL] [Abstract][Full Text] [Related]
15. Tumorigenicity of the diastereomeric benz[a]anthracene 3,4-diol-1,2-epoxides and the (+)- and (-)-enantiomers of benz[a]anthracene 3,4-dihydrodiol in newborn mice. Wislocki PG; Buening MK; Levin W; Lehr RE; Thakker DR; Jerina DM; Conney AH J Natl Cancer Inst; 1979 Jul; 63(1):201-4. PubMed ID: 286829 [TBL] [Abstract][Full Text] [Related]
16. Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline. Kumar S; Sikka HC; Dubey SK; Czech A; Geddie N; Wang CX; LaVoie EJ Cancer Res; 1989 Jan; 49(1):20-4. PubMed ID: 2908847 [TBL] [Abstract][Full Text] [Related]
17. Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides. Slaga TJ; Huberman E; Selkirk JK; Harvey RG; Bracken WM Cancer Res; 1978 Jun; 38(6):1699-704. PubMed ID: 647680 [TBL] [Abstract][Full Text] [Related]
18. Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides. Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Mah HD; Karle JM; Yagi H; Jerina DM; Conney AH Cancer Res; 1979 Oct; 39(10):4069-77. PubMed ID: 383279 [No Abstract] [Full Text] [Related]
19. Convenient syntheses of dibenzo[c,p]chrysene and its possible proximate and ultimate carcinogens: in vitro metabolism and DNA adduction studies. Sharma AK; Lin JM; Desai D; Amin S J Org Chem; 2005 Jun; 70(13):4962-70. PubMed ID: 15960493 [TBL] [Abstract][Full Text] [Related]
20. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites. Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]